Tailor an Options Trading Strategy to Fit Your Needs
This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.

Take your trading to the next level with the Options Strategy Guide.
Download your FREE Options Strategy Guide Today.

ABIO Insider Trading (ARCA biopharma)

Insider Ownership Percentage: 0.48%
Insider Buying (Last 12 Months): $1,205,974.29
Insider Selling (Last 12 Months): $0.00

ARCA biopharma Insider Trading History Chart

This chart shows the insider buying and selling history at ARCA biopharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

ARCA biopharma Share Price & Price History

Current Price: $2.47
Price Change: Price Decrease of -0.03 (-1.20%)
As of 06/30/2022 01:01 PM ET

This chart shows the closing price history over time for ABIO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Former Lawyer Went From $50K To $5.3M Trading Options
Slaving away for 70 hrs a week as a lawyer in Chicago, I was miserable.

I ran into guys who worked the trading floor at the local exchange. I began trading the same way they did. I started out with $50K (much more than I needed, actually).

I grew my $50K into $5.3M
I'll show you how I did it here.

ARCA biopharma Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/25/2022Fund Lp FunicularInsiderBuy64,851$2.32$150,454.322,580,452View SEC Filing Icon  
5/23/2022Fund Lp FunicularInsiderBuy2,301$2.29$5,269.292,497,491View SEC Filing Icon  
5/18/2022Fund Lp FunicularInsiderBuy13,072$2.30$30,065.602,495,189View SEC Filing Icon  
5/16/2022Fund Lp FunicularInsiderBuy42,914$2.30$98,702.202,482,117View SEC Filing Icon  
5/13/2022Fund Lp FunicularInsiderBuy14,000$2.29$32,060.002,439,203View SEC Filing Icon  
5/11/2022Fund Lp FunicularInsiderBuy24,596$2.29$56,324.842,397,281View SEC Filing Icon  
5/9/2022Fund Lp FunicularInsiderBuy49,221$2.27$111,731.672,351,706View SEC Filing Icon  
5/5/2022Fund Lp FunicularInsiderBuy16,903$2.27$38,369.812,244,487View SEC Filing Icon  
5/2/2022Fund Lp FunicularInsiderBuy1,259$2.31$2,908.292,227,584View SEC Filing Icon  
4/28/2022Fund Lp FunicularInsiderBuy23,381$2.32$54,243.922,217,351View SEC Filing Icon  
4/25/2022Fund Lp FunicularInsiderBuy13,751$2.29$31,489.792,193,970View SEC Filing Icon  
4/18/2022Fund Lp FunicularInsiderBuy9,119$2.31$21,064.892,180,219View SEC Filing Icon  
4/14/2022Fund Lp FunicularInsiderBuy17,410$2.33$40,565.302,171,100View SEC Filing Icon  
4/11/2022Fund Lp FunicularInsiderBuy4,655$2.31$10,753.052,084,292View SEC Filing Icon  
4/8/2022Fund Lp FunicularInsiderBuy30,660$2.31$70,824.602,079,637View SEC Filing Icon  
4/6/2022Fund Lp FunicularInsiderBuy26,806$2.30$61,653.80View SEC Filing Icon  
4/4/2022Fund Lp FunicularInsiderBuy122,342$2.26$276,492.922,048,977View SEC Filing Icon  
11/22/2021Christopher David OzeroffVPBuy50,000$2.26$113,000.00View SEC Filing Icon  
5/12/2021Robert E ConwayChairmanBuy10,000$3.19$31,900.0050,000View SEC Filing Icon  
5/5/2021Robert E ConwayChairmanBuy10,000$3.23$32,300.0040,000View SEC Filing Icon  
12/18/2020Robert E ConwayChairmanBuy10,000$4.16$41,600.0030,000View SEC Filing Icon  
9/25/2020Robert E ConwayChairmanBuy5,000$4.28$21,400.0020,000View SEC Filing Icon  
9/21/2020Robert E ConwayChairmanBuy10,000$4.77$47,700.0011,944View SEC Filing Icon  
See Full Table
Tailor an Options Trading Strategy to Fit Your Needs
This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.

Take your trading to the next level with the Options Strategy Guide.
Download your FREE Options Strategy Guide Today.

SEC Filings (Institutional Ownership Changes) for ARCA biopharma (NASDAQ:ABIO)

28.12% of ARCA biopharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ABIO by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

ARCA biopharma Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/17/2022Virtu Financial LLC23,874$55K0.0%N/A0.166%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.459,562$1.06M0.0%+13.1%3.189%Search for SEC Filing on Google Icon
4/26/2022Marquette Asset Management LLC17,318$40K0.0%N/A0.120%Search for SEC Filing on Google Icon
2/10/2022Acadian Asset Management LLC57,822$0.12M0.0%N/A0.401%Search for SEC Filing on Google Icon
11/15/2021GSA Capital Partners LLP441,945$1.31M0.1%+238.9%3.067%Search for SEC Filing on Google Icon
11/15/2021Minerva Advisors LLC10,000$30K0.0%N/A0.069%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.268,394$0.80M0.0%-1.8%1.863%Search for SEC Filing on Google Icon
8/16/2021State Street Corp69,037$0.24M0.0%N/A0.479%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC87,659$0.31M0.0%+10.7%0.608%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.398,507$1.39M0.0%+189.8%2.765%Search for SEC Filing on Google Icon
8/12/2021XTX Topco Ltd10,846$38K0.0%N/A0.075%Search for SEC Filing on Google Icon
8/5/2021GSA Capital Partners LLP130,395$0.46M0.1%+39.8%0.905%Search for SEC Filing on Google Icon
5/19/2021Virtu Financial LLC16,655$61K0.0%-32.4%0.116%Search for SEC Filing on Google Icon
5/17/2021PDT Partners LLC17,297$63K0.0%N/A0.120%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC79,151$0.29M0.0%+141.7%0.549%Search for SEC Filing on Google Icon
5/10/2021GSA Capital Partners LLP93,241$0.34M0.1%+102.3%0.647%Search for SEC Filing on Google Icon
2/24/2021Virtu Financial LLC24,641$99K0.0%N/A0.264%Search for SEC Filing on Google Icon
2/10/2021Renaissance Technologies LLC205,500$0.82M0.0%+436.4%2.205%Search for SEC Filing on Google Icon
2/10/2021Panagora Asset Management Inc.6,878$28K0.0%N/A0.074%Search for SEC Filing on Google Icon
2/4/2021GSA Capital Partners LLP46,097$0.19M0.0%N/A0.495%Search for SEC Filing on Google Icon
11/19/2020Schonfeld Strategic Advisors LLC18,200$80K0.0%N/A0.195%Search for SEC Filing on Google Icon
11/17/2020Schonfeld Strategic Advisors LLC18,200$80K0.0%N/A0.195%Search for SEC Filing on Google Icon
11/6/2020BlackRock Inc.287,263$1.27M0.0%+598,364.6%4.865%Search for SEC Filing on Google Icon
8/13/2020Tekla Capital Management LLC32,461$0.22M0.0%-10.0%0.550%Search for SEC Filing on Google Icon
5/11/2020Acadian Asset Management LLC28,423$80K0.0%+64.0%1.788%Search for SEC Filing on Google Icon
2/13/2020Renaissance Technologies LLC142,572$0.81M0.0%+42.4%8.944%Search for SEC Filing on Google Icon
8/12/2019Renaissance Technologies LLC80,485$0.59M0.0%-91.1%5.528%Search for SEC Filing on Google Icon
8/12/2019Quantamental Technologies LLC5,148$38K0.0%N/A0.353%Search for SEC Filing on Google Icon
8/8/2019Acadian Asset Management LLC17,333$0.13M0.0%-92.1%1.187%Search for SEC Filing on Google Icon
8/6/2019Aveo Capital Partners LLC95,715$0.66M0.3%+2.6%6.574%Search for SEC Filing on Google Icon
11/13/2018Renaissance Technologies LLC670,459$0.38M0.0%+59.9%4.817%Search for SEC Filing on Google Icon
11/13/2018Virtu Financial LLC176,131$0.54M0.0%+416.1%1.265%Search for SEC Filing on Google Icon
8/13/2018Renaissance Technologies LLC419,250$0.23M0.0%-21.4%3.012%Search for SEC Filing on Google Icon
2/13/2018Renaissance Technologies LLC129,705$0.18M0.0%-45.2%1.104%Search for SEC Filing on Google Icon
2/9/2018Royce & Associates LP324,847$0.45M0.0%+38.3%2.765%Search for SEC Filing on Google Icon
11/14/2017Royce & Associates LP234,847$0.26M0.0%+30.6%1.999%Search for SEC Filing on Google Icon
8/14/2017Tekla Capital Management LLC811,227$1.99M0.1%No Change6.904%Search for SEC Filing on Google Icon
8/10/2017Franklin Resources Inc.1,216,840$2.98M0.0%No Change13.166%Search for SEC Filing on Google Icon
8/7/2017Royce & Associates LP179,847$0.44M0.0%+476.4%1.946%Search for SEC Filing on Google Icon
8/1/2017Aveo Capital Partners LLC93,667$0.23M0.1%+93.7%1.013%Search for SEC Filing on Google Icon
7/26/2017NEA Management Company LLC1,460,209$3.51M0.1%No Change15.800%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
ARCA biopharma logo
ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases. Its lead product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), which is in Phase IIb clinical trial for the treatment for COVID-19; and Gencaro (bucindolol hydrochloride), a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase IIb trial for the treatment of atrial fibrillation in patients with chronic heart failure. ARCA biopharma, Inc. has a collaboration agreement with LabCorp to develop genetic test for GENETIC-AF clinical trial; and research collaboration with Colorado Prevention Center, the University of Colorado's Academic Research Organization to develop and commercialize Gencaro. The company was incorporated in 2004 and is headquartered in Westminster, Colorado.
Read More on ARCA biopharma

Today's Range

Now: $2.47
Low: $2.47
High: $2.47

50 Day Range

MA: $2.36
Low: $2.24
High: $2.53

52 Week Range

Now: $2.47
Low: $1.71
High: $3.84

Volume

500 shs

Average Volume

127,347 shs

Market Capitalization

$35.59 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.2

Who are the company insiders with the largest holdings of ARCA biopharma?

ARCA biopharma's top insider investors include:
  1. Fund Lp Funicular (Insider)
  2. Robert E Conway (Chairman)
  3. Christopher David Ozeroff (VP)
Learn More about top insider investors at ARCA biopharma.
New Investing App Saves Investors an Average of $97,347
Most people are terrible at buying and selling stocks at the right time, but the TradeSmith app takes the emotion out of investing.

Our back test shows, the average investor would've made $97,347 more just by using the TradeSmith app analyzer software.

Check out this FREE video.
>>>